Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay
- 1 August 1993
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 28 (2) , 162-167
- https://doi.org/10.1016/0167-8140(93)90009-w
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 25 references indexed in Scilit:
- Carbogen and nicotinamide: expectations too high?Radiotherapy and Oncology, 1992
- A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatmentsRadiotherapy and Oncology, 1991
- The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivoRadiotherapy and Oncology, 1990
- Use of the Micronucleus Assay for the Selective Detection of Radiosensitivity in BUdR-unincorporated Cells after Pulse-labelling of Exponentially Growing Tumour CellsInternational Journal of Radiation Biology, 1990
- Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 studyInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Response of human tumour xenografts to fractionated X-irradiationRadiotherapy and Oncology, 1986
- Reactions to niacinamideJournal of the American Academy of Dermatology, 1981
- Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenationThe British Journal of Radiology, 1979
- Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude miceThe British Journal of Radiology, 1979
- A rapid in vivo test for chromosomal damage☆Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1973